Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004).
Toyoda M, Ajiki T, Fujiwara Y, Nagano H, Kobayashi S, Sakai D, Hatano E, Kanai M, Nakamori S, Miyamoto A, Tsuji A, Kaihara S, Ikoma H, Takemura S, Toyokawa H, Terajima H, Morita S, Ioka T. Toyoda M, et al. Among authors: terajima h. Cancer Chemother Pharmacol. 2014 Jun;73(6):1295-301. doi: 10.1007/s00280-014-2431-y. Epub 2014 Mar 11. Cancer Chemother Pharmacol. 2014. PMID: 24614947 Free PMC article. Clinical Trial.
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
Hatano E, Okuno M, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S. Hatano E, et al. Among authors: terajima h. J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):634-45. doi: 10.1002/jhbp.254. Epub 2015 Apr 29. J Hepatobiliary Pancreat Sci. 2015. PMID: 25926024 Clinical Trial.
ALPlat criterion for the resection of hepatocellular carcinoma based on a predictive model of posthepatectomy liver failure.
Yamamoto G, Taura K, Ikai I, Fujikawa T, Nishitai R, Kaihara S, Zaima M, Terajima H, Yoshimura T, Koyama Y, Tanabe K, Nishio T, Okuda Y, Ikeno Y, Yoshino K, Fukuyama K, Seo S, Hatano E, Uemoto S. Yamamoto G, et al. Among authors: terajima h. Surgery. 2020 Feb;167(2):410-416. doi: 10.1016/j.surg.2019.09.021. Epub 2019 Nov 11. Surgery. 2020. PMID: 31727326
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Okuno M, Hatano E, Toda R, Nishino H, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokuka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S. Okuno M, et al. Among authors: terajima h. J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):496-509. doi: 10.1002/jhbp.747. Epub 2020 Jun 9. J Hepatobiliary Pancreat Sci. 2020. PMID: 32362018 Free article. Clinical Trial.
102 results